Annual Non Current Assets
$516.60 K
+$248.10 K+92.40%
December 31, 2023
Summary
- As of February 7, 2025, ALDX annual long term assets is $516.60 thousand, with the most recent change of +$248.10 thousand (+92.40%) on December 31, 2023.
- During the last 3 years, ALDX annual non current assets has risen by +$223.40 thousand (+76.19%).
- ALDX annual non current assets is now at all-time high.
Performance
ALDX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$598.60 K
+$204.30 K+51.81%
September 30, 2024
Summary
- As of February 7, 2025, ALDX quarterly long term assets is $598.60 thousand, with the most recent change of +$204.30 thousand (+51.81%) on September 30, 2024.
- Over the past year, ALDX quarterly non current assets has increased by +$526.40 thousand (+729.09%).
- ALDX quarterly non current assets is now -47.12% below its all-time high of $1.13 million, reached on March 31, 2019.
Performance
ALDX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ALDX Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +92.4% | +729.1% |
3 y3 years | +76.2% | +34.3% |
5 y5 years | +60.5% | +42.3% |
ALDX Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +92.4% | at high | +729.1% |
5 y | 5-year | at high | +92.4% | at high | +729.1% |
alltime | all time | at high | -100.0% | -47.1% | -100.0% |
Aldeyra Therapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $598.60 K(+51.8%) |
Jun 2024 | - | $394.30 K(-13.5%) |
Mar 2024 | - | $455.90 K(-11.7%) |
Dec 2023 | $147.81 M(-18.3%) | $516.60 K(+615.5%) |
Sep 2023 | - | $72.20 K(-47.4%) |
Jun 2023 | - | $137.20 K(-31.9%) |
Mar 2023 | - | $201.60 K(-24.9%) |
Dec 2022 | $181.02 M(-22.2%) | $268.50 K(+28.7%) |
Sep 2022 | - | $208.60 K(-23.8%) |
Jun 2022 | - | $273.90 K(-18.9%) |
Mar 2022 | - | $337.90 K(-12.1%) |
Dec 2021 | $232.75 M(+180.2%) | $384.40 K(-13.7%) |
Sep 2021 | - | $445.60 K(+167.6%) |
Jun 2021 | - | $166.50 K(-28.6%) |
Mar 2021 | - | $233.20 K(-20.5%) |
Dec 2020 | $83.06 M(+10.5%) | $293.20 K(+122.8%) |
Sep 2020 | - | $131.60 K(-35.7%) |
Jun 2020 | - | $204.80 K(-26.2%) |
Mar 2020 | - | $277.40 K(-20.6%) |
Dec 2019 | $75.17 M(-20.7%) | $349.50 K(-16.9%) |
Sep 2019 | - | $420.60 K(-57.2%) |
Jun 2019 | - | $983.10 K(-13.1%) |
Mar 2019 | - | $1.13 M(+251.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $94.77 M(+115.6%) | $321.90 K(+12.4%) |
Sep 2018 | - | $286.50 K(+33.4%) |
Jun 2018 | - | $214.70 K(+25.6%) |
Mar 2018 | - | $170.90 K(-18.3%) |
Dec 2017 | $43.97 M(+74.9%) | $209.20 K(+18.4%) |
Sep 2017 | - | $176.70 K(+40.3%) |
Jun 2017 | - | $125.90 K(+116.0%) |
Mar 2017 | - | $58.30 K(+3.4%) |
Dec 2016 | $25.13 M(-10.5%) | $56.40 K(-14.2%) |
Sep 2016 | - | $65.70 K(-12.4%) |
Jun 2016 | - | $75.00 K(-41.2%) |
Mar 2016 | - | $127.50 K(+9.3%) |
Dec 2015 | $28.09 M(+220.6%) | $116.60 K(-6.5%) |
Sep 2015 | - | $124.70 K(+204.9%) |
Jun 2015 | - | $40.90 K(+23.2%) |
Mar 2015 | - | $33.20 K(+22.1%) |
Dec 2014 | $8.76 M(+167.8%) | $27.20 K(+369.0%) |
Sep 2014 | - | $5800.00(>+9900.0%) |
Jun 2014 | - | $0.00(-100.0%) |
Mar 2014 | - | $735.20 K(+55.6%) |
Dec 2013 | $3.27 M(+65.4%) | $472.50 K(+845.0%) |
Sep 2013 | - | $50.00 K(>+9900.0%) |
Dec 2012 | $1.98 M(+674.7%) | $0.00 |
Dec 2011 | $255.20 K | - |
FAQ
- What is Aldeyra Therapeutics annual long term assets?
- What is the all time high annual non current assets for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual non current assets year-on-year change?
- What is Aldeyra Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly non current assets year-on-year change?
What is Aldeyra Therapeutics annual long term assets?
The current annual non current assets of ALDX is $516.60 K
What is the all time high annual non current assets for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual long term assets is $516.60 K
What is Aldeyra Therapeutics annual non current assets year-on-year change?
Over the past year, ALDX annual long term assets has changed by +$248.10 K (+92.40%)
What is Aldeyra Therapeutics quarterly long term assets?
The current quarterly non current assets of ALDX is $598.60 K
What is the all time high quarterly non current assets for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly long term assets is $1.13 M
What is Aldeyra Therapeutics quarterly non current assets year-on-year change?
Over the past year, ALDX quarterly long term assets has changed by +$526.40 K (+729.09%)